Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
burosumab fibroblast growth factor-23 NA Successful target TTD , DGIDB Bone Diseases[MeSHID:D001847]
Hypophosphatemic Rickets
X-Linked Dominant[MeSHID:D053098]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 254.61 approved inhibitor
burosumab fibroblast growth factor 23 biotech NA drugbank , DGIDB Bone Diseases[MeSHID:D001847]
Hypophosphatemic Rickets
X-Linked Dominant[MeSHID:D053098]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 254.61 approved,investigational antagonist,inhibitor
burosumab fibroblast growth factor-23 NA Successful target TTD , DGIDB Bone Diseases[MeSHID:D001847]
Hypophosphatemic Rickets
X-Linked Dominant[MeSHID:D053098]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 254.61 approved unknown
burosumab fibroblast growth factor 23 biotech NA drugbank , DGIDB Bone Diseases[MeSHID:D001847]
Hypophosphatemic Rickets
X-Linked Dominant[MeSHID:D053098]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 254.61 approved,investigational antagonist
click here to return to the previous page